Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
52.39
+1.51 (+2.97%)
Official Closing Price
Updated: 7:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,138,559
Open
51.61
Bid (Size)
52.48 (200)
Ask (Size)
52.50 (200)
Prev. Close
50.88
Today's Range
51.41 - 52.41
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
4.20%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026
↗
January 03, 2026
The pharmaceutical leader looks poised to stop the bleeding.
Via
The Motley Fool
The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls
January 02, 2026
Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
Performance
YTD
N/A
N/A
1 Month
+9.2%
+9.2%
3 Month
-12.2%
-12.2%
6 Month
-24.4%
-24.4%
1 Year
-40.2%
-40.2%
More News
Read More
The GLP-1 Pricing Revolution: How Novo Nordisk and Eli Lilly Redefined the Weight-Loss Market for 2026
January 02, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
January 01, 2026
Via
MarketMinute
Topics
Intellectual Property
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
FDA Approves Novo Nordisk's Wegovy Pill: A Game Changer for 2026
↗
December 31, 2025
Via
MarketBeat
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Why Novo Nordisk Stock Dropped on Monday
↗
December 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
December 30, 2025
Via
MarketMinute
Topics
ETFs
Economy
World Trade
The 2026 Horizon: Wall Street Bets on the 'Application Era' and the Nuclear Renaissance
December 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via
MarketMinute
Topics
ETFs
Intellectual Property
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
December 29, 2025
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset
December 29, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
Economy
This Beaten-Down Stock Just Jumped By 8%. Time to Buy?
↗
December 29, 2025
Via
The Motley Fool
Novo Nordisk Slashes Weight Loss Drug Price By Up To 50% In China: Report
↗
December 29, 2025
Via
Stocktwits
Topics
Intellectual Property
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA.
↗
December 29, 2025
Via
The Motley Fool
3 Drug Stocks to Buy at a Discount
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
Should You Invest in Ozempic Maker Novo Nordisk in 2026?
↗
December 26, 2025
Via
The Motley Fool
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026
↗
December 26, 2025
Via
MarketBeat
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling
↗
December 26, 2025
Via
Stocktwits
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree
↗
December 26, 2025
Via
The Motley Fool
Betting on the 'Santa Squeeze': Unusual Options Activity Surges as 2025 Draws to a Close
December 25, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?
↗
December 25, 2025
Via
The Motley Fool
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
December 25, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 52.39
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.